![]()
|
|
||||||||
(Received for publication, January 30, 1995; and in revised form, January 12, 1996) Parathyroid hormone and other agents that stimulate bone
resorption function, at least in part, by inducing osteoblasts to
secrete cytokines that stimulate osteoclast differentiation and
activity. We previously demonstrated that parathyroid hormone induces
expression by osteoblasts of interleukin-6 and leukemia inhibitory
factor without affecting the 16 other cytokines that were examined. We
also showed that stimulation of osteoclast activity by parathyroid
hormone is dependent on activation of the cAMP signal transduction
pathway and secretion of interleukin-6 by osteoblasts. In the current
study, we demonstrate that the rapid and transient stimulation of
interleukin-6 and leukemia inhibitory factor is inhibited by
actinomycin D and superinduced by protein synthesis inhibitors, the
classical characteristics of an immediate-early gene response.
Moreover, activation of cAMP signal transduction by parathyroid hormone
and parathyroid hormone-related protein is necessary and sufficient to
induce both interleukin-6 and leukemia inhibitory factor. In addition,
cAMP analogues as well as vasoactive intestinal peptide and
isoproterenol, two neuropeptides that stimulate bone resorption by
activating cAMP signal transduction in osteoblasts, also induce
interleukin-6 and leukemia inhibitory factor in these cells. Taken
together with our previous results, this study suggests that
interleukin-6 is crucial for stimulation of bone resorption not only by
parathyroid hormone, but also by parathyroid hormone-related protein,
vasoactive intestinal peptide, and
Volume 271,
Number 18,
Issue of May 3, 1996 pp. 10984-10989
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
-adrenergic agonists, like
isoproterenol.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Lorenzo, M. Horowitz, and Y. Choi Osteoimmunology: Interactions of the Bone and Immune System Endocr. Rev., June 1, 2008; 29(4): 403 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Nakchbandi, R. Lang, B. Kinder, and K. L. Insogna The Role of the Receptor Activator of Nuclear Factor-{kappa}B Ligand/Osteoprotegerin Cytokine System in Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 967 - 973. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Falconi, K. Oizumi, and J. E. Aubin Leukemia Inhibitory Factor Influences the Fate Choice of Mesenchymal Progenitor Cells Stem Cells, February 1, 2007; 25(2): 305 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hinoi, T. Ueshima, H. Hojo, M. Iemata, T. Takarada, and Y. Yoneda Up-regulation of per mRNA Expression by Parathyroid Hormone through a Protein Kinase A-CREB-dependent Mechanism in Chondrocytes J. Biol. Chem., August 18, 2006; 281(33): 23632 - 23642. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Taichman Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche Blood, April 1, 2005; 105(7): 2631 - 2639. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, J.-C. Dai, S. A. Orellana, and E. M. Greenfield Endogenous Protein Kinase Inhibitor {gamma} Terminates Immediate-early Gene Expression Induced by cAMP-dependent Protein Kinase (PKA) Signaling: TERMINATION DEPENDS ON PKA INACTIVATION RATHER THAN PKA EXPORT FROM THE NUCLEUS J. Biol. Chem., January 28, 2005; 280(4): 2700 - 2707. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Ozkurt, F. Q. Pirih, and S. Tetradis Parathyroid Hormone Induces E4bp4 Messenger Ribonucleic Acid Expression Primarily through Cyclic Adenosine 3',5'-Monophosphate Signaling in Osteoblasts Endocrinology, August 1, 2004; 145(8): 3696 - 3703. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, J.-C. Dai, and E. M. Greenfield Termination of immediate-early gene expression after stimulation by parathyroid hormone or isoproterenol Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1432 - C1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Huening, G. Yehia, C. A. Molina, and S. Christakos Evidence for a Regulatory Role of Inducible cAMP Early Repressor in Protein Kinase A-Mediated Enhancement of Vitamin D Receptor Expression and Modulation of Hormone Action Mol. Endocrinol., September 1, 2002; 16(9): 2052 - 2064. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. S. Masiukiewicz, M. Mitnick, B. I. Gulanski, and K. L. Insogna Evidence that the IL-6/IL-6 Soluble Receptor Cytokine System Plays a Role in the Increased Skeletal Sensitivity to PTH in Estrogen-Deficient Women J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2892 - 2898. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Arnulf, D. Bengoufa, E. Sarfati, M.-E. Toubert, V. Meignin, J.-C. Brouet, and J.-P. Fermand Prevalence of Monoclonal Gammopathy in Patients With Primary Hyperparathyroidism: A Prospective Study Arch Intern Med, February 25, 2002; 162(4): 464 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Nakchbandi, M. A. Mitnick, U. S. Masiukiewicz, B. h. Sun, and K. L. Insogna IL-6 Negatively Regulates IL-11 Production in Vitro and in Vivo Endocrinology, September 1, 2001; 142(9): 3850 - 3856. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tetradis, O. Bezouglaia, and A. Tsingotjidou Parathyroid Hormone Induces Expression of the Nuclear Orphan Receptor Nurr1 in Bone Cells Endocrinology, February 1, 2001; 142(2): 663 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Miles, J. P. Sluka, D. L. Halladay, R. F. Santerre, L. V. Hale, L. Bloem, K. Thirunavukkarasu, R. J. S. Galvin, J. M. Hock, and J. E. Onyia ADAMTS-1: A Cellular Disintegrin and Metalloprotease with Thrombospondin Motifs Is a Target for Parathyroid Hormone in Bone Endocrinology, December 1, 2000; 141(12): 4533 - 4542. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. S. Masiukiewicz, M. Mitnick, A. B. Grey, and K. L. Insogna Estrogen Modulates Parathyroid Hormone-Induced Interleukin-6 Production in Vivo and in Vitro Endocrinology, July 1, 2000; 141(7): 2526 - 2531. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Auernhammer and S. Melmed Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function Endocr. Rev., June 1, 2000; 21(3): 313 - 345. [Abstract] [Full Text] |
||||
![]() |
N. Selvamurugan, M. R. Pulumati, D. R. Tyson, and N. C. Partridge Parathyroid Hormone Regulation of the Rat Collagenase-3 Promoter by Protein Kinase A-dependent Transactivation of Core Binding Factor alpha 1 J. Biol. Chem., February 18, 2000; 275(7): 5037 - 5042. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. DE MIGUEL, P. MARTINEZ-FERNANDEZ, C. GUILLEN, A. VALIN, A. RODRIGO, M. E. MARTINEZ, and P. ESBRIT Parathyroid Hormone-Related Protein (107-139) Stimulates Interleukin-6 Expression in Human Osteoblastic Cells J. Am. Soc. Nephrol., April 1, 1999; 10(4): 796 - 803. [Abstract] [Full Text] |
||||
![]() |
O. A. Adebanjo, B. S. Moonga, T. Yamate, L. Sun, C. Minkin, E. Abe, and M. Zaidi Mode of Action of Interleukin-6 on Mature Osteoclasts. Novel Interactions with Extracellular Ca2+ Sensing in the Regulation of Osteoclastic Bone Resorption J. Cell Biol., September 7, 1998; 142(5): 1347 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Mohney and R. E. Zigmond Vasoactive Intestinal Peptide Enhances Its Own Expression in Sympathetic Neurons after Injury J. Neurosci., July 15, 1998; 18(14): 5285 - 5293. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Taichman and S. G. Emerson The Role of Osteoblasts in the Hematopoietic Microenvironment Stem Cells, January 1, 1998; 16(1): 7 - 15. [Abstract] [Full Text] |
||||
![]() |
B. A. Habecker, A. J. Symes, N. Stahl, N. J. Francis, A. Economides, J. S. Fink, G. D. Yancopoulos, and S. C. Landis A Sweat Gland-derived Differentiation Activity Acts through Known Cytokine Signaling Pathways J. Biol. Chem., November 28, 1997; 272(48): 30421 - 30428. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. BLAINE, P. F. POLLICE, R. N. ROSIER, P. R. REYNOLDS, J. E. PUZAS, and R. J. O'KEEFE Modulation of the Production of Cytokines in Titanium-Stimulated Human Peripheral Blood Monocytes by Pharmacological Agents. The Role of cAMP-Mediated Signaling Mechanisms*{{dagger}} J. Bone Joint Surg. Am., October 1, 1997; 79(10): 1519 - 28. [Abstract] [Full Text] |
||||
![]() |
S. Tetradis, C. C. Pilbeam, Y. Liu, H. R. Herschman, and B. E. Kream Parathyroid Hormone Increases Prostaglandin G/H Synthase-2 Transcription by a Cyclic Adenosine 3',5'-Monophosphate-Mediated Pathway in Murine Osteoblastic MC3T3-E1 Cells Endocrinology, September 1, 1997; 138(9): 3594 - 3600. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |